Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylergonovine maleate injection for prevention of postpartum hemorrhage after cesarean section
CTR20150791Phase 3Active
- Sponsor
- Sunstone Pharmaceutical
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylergometrine in postpartum hemorrhage (PPH), sponsored by Sunstone Pharmaceutical. Started Mar 2016; status: active.
02
Drugs
methylergometrine
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on CTR20150791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150791.